You'd be wrong to think the ancient Greek gods bled red like you and me, as ichor was the substance that defined their ...
As of Thursday, February 26, Ichor Holdings, Ltd.’s ICHR share price has dipped by 9.69%, which has investors questioning if this is right time to buy.
Ichor Holdings, Ltd. (NASDAQ: ICHR), a leader in the design, engineering, and manufacturing of critical fluid delivery ...
Ichor Holdings, Ltd. targets a $60 price and 15% margins via global expansion and increased semi-cap market share gains. Find ...
Ichor Holdings (NASDAQ: ICHR) surged higher Tuesday. The fluid-delivery-subsystems company's share price closed out the daily session up 32.7%. Meanwhile, the S&P 500 was down 0.4% and the Nasdaq ...
Investors might want to bet on Ichor Holdings (ICHR), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward ...
FREMONT, Calif.--(BUSINESS WIRE)--Ichor Holdings, Ltd. (NASDAQ:ICHR), a leader in the design, engineering and manufacturing of critical fluid delivery subsystems for semiconductor capital equipment, ...
SAN DIEGO--(BUSINESS WIRE)--Ichor Medical Systems, Inc. (Ichor) announced today the first in human dosing of JNJ-64300535 with its next generation investigational TriGrid ® Delivery System. This DNA ...
Investors cheered the company's preliminary results and guidance. Ichor expects to produce first-quarter revenue of $148.7 million, toward the high end of its previous guidance range of $140 million ...
Ichor's fourth-quarter report arrived with sales and earnings that were better than Wall Street expected. The company expects sales will grow in a sequential basis in each quarter this year. Ichor ...
The company released preliminary results and guidance. Revenue in the fourth quarter will be approximately $189 million, at the high end of the company's guidance of $180 million to $190 million. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results